The global landscape of renal treatment is switching speedily. With the global increase of chronic kidney disorder (CKD), hypertension, and diabetic issues, the stress on nephrology departments, specialized dialysis centers, and transplant units has intensified significantly. For B2B companies—which include healthcare system brands of hemodialysi